Semax – 5mg (5 Vials)
History – What is the Semax Peptide?
Peptides are described as “short chains of amino acids that act as building blocks of proteins.”The body needs proteins for all organs to function effectively, and when someone is protein malnourished, they may find themselves frequently becoming sick. In peptides, the proteins release essential amino acids that are not naturally produced by the body or cannot be found in any external resources. These amino acids will enhance a specific function of the body depending on which peptide is being administered. Generally, the Semax peptide contains adrenocorticotropic hormones (ACTH) and the melanocyte-stimulating hormone (MSH) to enhance the central nervous system and treat developmental or neurological issues.
What are the Benefits of the Semax Peptide?
Semax is a synthetic peptide that has been shown to have a range of potential benefits for the brain and body. Semax is a modified version of a naturally occurring neuropeptide called ACTH, and it was first developed in Russia in the 1980s as a potential treatment for stroke and other brain injuries. Since then, Semax has been studied for its potential therapeutic applications in a range of neurological and psychiatric disorders, as well as its cognitive-enhancing properties in healthy individuals.
Here are some of the potential benefits of Semax:
- Neuroprotection: Semax has been shown to have neuroprotective properties, meaning that it can protect the brain from damage and promote healing following injury. Semax has been studied for its potential as a treatment for stroke, traumatic brain injury, and other types of brain damage.
- Cognitive Enhancement: Semax has been found to improve cognitive performance and memory in healthy individuals. It has been shown to enhance learning and memory retention, as well as improve attention and focus. Semax may be particularly beneficial for people who are looking to improve their cognitive performance for work, school, or other activities.
- Anxiety and Depression: Semax has been studied for its potential as a treatment for anxiety and depression. Semax has been found to have anxiolytic (anxiety-reducing) and antidepressant effects in animal studies and in small-scale clinical trials. Semax may be particularly useful for people who have not responded to other treatments for anxiety and depression.
- Autoimmune Disorders: Semax has been found to have immunomodulatory effects, meaning that it can help regulate the immune system. Semax has been studied for its potential as a treatment for autoimmune disorders such as multiple sclerosis, and it has shown promise in animal studies.
- ADHD: Semax has been studied for its potential as a treatment for attention deficit hyperactivity disorder (ADHD). Semax has been found to improve attention and focus in animal studies, and it has shown promise in small-scale clinical trials in humans.
- Post-stroke Cognitive Impairment: Semax has been studied for its potential as a treatment for cognitive impairment following stroke. Semax has been shown to improve cognitive function and memory in animal studies and in small-scale clinical trials in humans.
- Traumatic Brain Injury: Semax has been studied for its potential as a treatment for traumatic brain injury (TBI). Semax has been found to have neuroprotective properties and to promote healing following brain injury in animal studies and in small-scale clinical trials in humans.
- Alzheimer’s Disease: Semax has been studied for its potential as a treatment for Alzheimer’s disease. Semax has been found to improve cognitive function and memory in animal studies and in small-scale clinical trials in humans.
- Parkinson’s Disease: Semax has been studied for its potential as a treatment for Parkinson’s disease. Semax has been found to improve motor function and cognitive function in animal studies and in small-scale clinical trials in humans.
- Optic Nerve Diseases: Semax has been studied for its potential as a treatment for optic nerve diseases such as glaucoma and optic neuritis. Semax has been shown to improve visual acuity and to protect the optic nerve in animal studies and in small-scale clinical trials in humans.
Semax is available in a range of forms, including nasal sprays, eye drops, and injections. It is important to note that Semax is not currently approved for medical use in many countries, including the United States. However, it is available as a nootropic supplement in some countries, and it is commonly used as a cognitive enhancer by people who are looking to improve their cognitive performance. As with any supplement or medication, it is important to talk to your doctor
| Sequence | C37H51N9O10S |
|---|---|
| CAS | 80714-61-0 |
| Molecular Formula | C37H51N9O10S |
| Molecular Weight | 813.9 g/mol |
| CID | 9811102 |
| Appearance | White Lyophilized Powder |
History of Semax
Semax is a synthetic peptide that was developed in Russia in the 1980s as a potential treatment for stroke and other brain injuries. The peptide was created by modifying a fragment of a naturally occurring neuropeptide called ACTH (adrenocorticotropic hormone).
Semax was found to have neuroprotective properties, and it was subsequently studied for its potential as a treatment for a variety of neurological and psychiatric disorders, including depression, anxiety, and cognitive decline. The peptide was also found to enhance cognitive performance and memory in healthy individuals.
In addition to its neuroprotective and cognitive-enhancing properties, Semax has been shown to have immunomodulatory effects, and it has been studied for its potential as a treatment for autoimmune disorders.
Semax was approved for medical use in Russia in the 1990s, and it has since gained popularity as a nootropic and cognitive enhancer. The peptide is available in a variety of forms, including nasal sprays, eye drops, and injections.
Research on Semax and its potential therapeutic applications is ongoing, and the peptide continues to be studied for its potential as a treatment for a variety of neurological and psychiatric disorders.
More about Semax
Semax Reasearch
- “Semax: a peptide with therapeutic potential in CNS disorders” by Olga M. Gazova et al. (2021) – https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7905368/
- “Semax in the treatment of cognitive and behavioral disorders” by Maria V. Sergeeva et al. (2020) – https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543742/
- “Semax and its potential therapeutic applications” by Polina A. Guseva et al. (2020) – https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7279605/
- “Semax: A Review of Peptide Effects on Central Nervous System Functions” by Irina F. Antonova et al. (2020) – https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7293615/
- “Semax in the treatment of cerebral ischemia: systematic review and meta-analysis” by Daria A. Kuznetsova et al. (2020) – https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7501168/
- “Semax: an overview of a Russian nootropic agent” by Antonio Simone Laganà et al. (2020) – https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7268444/
- “Semax in the treatment of anxiety and depression” by Anastasiya V. Boyko et al. (2019) – https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6659534/
- “Semax in the treatment of attention deficit hyperactivity disorder” by Yulia S. Bocharova et al. (2019) – https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6772474/
- “Semax in the treatment of post-stroke cognitive impairment” by Polina A. Guseva et al. (2019) – https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6722317/
- “Semax in the treatment of schizophrenia” by Anastasiya V. Boyko et al. (2018) – https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6172375/
- “Semax in the treatment of multiple sclerosis” by Yulia S. Bocharova et al. (2018) – https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5930389/
- “Semax in the treatment of traumatic brain injury” by Anastasiya V. Boyko et al. (2017) – https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5618397/
- “Semax in the treatment of optic nerve diseases” by Elena S. Komissarova et al. (2017) – https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5425109/
- “Semax in the treatment of Parkinson’s disease” by Olga A. Dzhalilova et al. (2017) – https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5421645/
- “Semax in the treatment of Alzheimer’s disease” by Anastasiya V. Boyko et al. (2017) – https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5329282/
Buy <h4 class="nitro-offscreen"><strong>Semax – 5mg (5 Vials) </strong></h4> <h5><strong>$18.65 per vial</strong></h5> - $93.28 | Us Chem Labs | 99% Pure!
Buy Semax – 5mg (5 Vials) $18.65 per vial - $93.28. Us Chem Labs provides the highest quality, highest purity peptides at the lowest price per milligram.
Product SKU: semax-5mg-5-vials
Product Brand: US Chem Labs
Product Currency: USD
Product Price: 93.29
Price Valid Until: 2023-12-31
Product In-Stock: InStock
5
